These findings indicate that liraglutide ameliorates the T2DM-associated NAFLD, which possibly through the activation of AMPK/ACC pathway and inhibition of ferroptosis. The gene discussed is ACACA; the disease is metabolic dysfunction-associated steatotic liver disease.